Tatsuya Yoshida

Re-biopsy status among non-small cell lung cancer patients in Japan: A retrospective study

Kaname Nosaki, Miyako Satouchi, Takayasu Kurata et al. · Lung Cancer · 2016 · 135 citations · Full text

RECIST progression patterns during EGFR tyrosine kinase inhibitor treatment of advanced non-small cell lung cancer patients harboring an EGFR mutation

Tatsuya Yoshida, Kiyotaka Yoh, Seiji Niho et al. · Lung Cancer · 2015 · 50 citations

Medicine, Pathology, Cancer Genomics +7

Association Between EGFR T790M Status and Progression Patterns During Initial EGFR-TKI Treatment in Patients Harboring EGFR Mutation

Yuko Oya, Tatsuya Yoshida, Hiroaki Kuroda et al. · Clinical Lung Cancer · 2017 · 39 citations

Urology, Oncology, Medicine +8

Solid predominant histology predicts EGFR tyrosine kinase inhibitor response in patients with EGFR mutation-positive lung adenocarcinoma

Tatsuya Yoshida, Genichiro Ishii, Kōichi Goto et al. · Journal of Cancer Research and Clinical Oncology · 2013 · 37 citations · Full text

Solid Predominant Histology, Medicine, Pathology +6

Serum ProGRP and NSE levels predicting small cell lung cancer transformation in a patient with ALK rearrangement‑positive non‑small cell lung cancer: A case report

Yuko Oya, Tatsuya Yoshida, Takehiro Uemura et al. · Oncology Letters · 2018 · 36 citations · Full text

Pathology, Cancer Biology, Tumor Biology +17